請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56512
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 黃青真(Ching-Jang Huang) | |
dc.contributor.author | Wen-Lung Chiang | en |
dc.contributor.author | 蔣汶龍 | zh_TW |
dc.date.accessioned | 2021-06-16T05:32:19Z | - |
dc.date.available | 2017-08-21 | |
dc.date.copyright | 2014-08-21 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-13 | |
dc.identifier.citation | Aguer C, Harper ME. (2012) Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: endocrine aspects. Best Pract Res Clin Endocrinol Metab. 26:805-19.
Aguirre V, Uchida T, Yenush L, Davis R, White MF. (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 275:9047-54. Ahmad N, Hassan MR, Haldar H. (1999) Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Med Res Coun Bull. 25:11–13. Allister EM, Robson-Doucette CA, Prentice KJ, Hardy AB, Sultan S, Gaisano HY, Kong D, Gilon P, Herrera PL, Lowell BB, Wheeler MB. (2013) UCP2 regulates the glucagon response to fasting and starvation. Diabetes. 62:1623–33. American Diabetes Association. (2010) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 33:S62-69. Andreux PA, Houtkooper RH, Auwerx J. (2013) Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov. 12:465-83. Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR. (2010) Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem. 285:21590-9. Ariyaratne HB, Mendis-Handagama SM. (2012) Thyroid hormone and anti-Mullerian hormone (AMH) on Leydig cell differentiation: studies using C57BL/6 mice and AMH over expressing mice. Histol Histopathol. 27:365-76. Asmann YW, Stump CS, Short KR, Coenen-Schimke JM, Guo Z, Bigelow ML, Nair KS. (2006) Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes. 55:3309-19. Auwerx J. Improving metabolism by increasing energy expenditure. (2006) Nature Med. 12:44–45. Bahi L, Garnier A, Fortin D, Serrurier B, Veksler V, Bigard AX, Ventura-Clapier R. (2005) Differential effects of thyroid hormones on energy metabolism of rat slow- and fast-twitch muscles. J Cell Physiol. 203:589-98. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J. (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13:461-8. Barbe P, Larrouy D, Boulanger C, Chevillotte E, Viguerie N, Thalamas C, Oliva Trastoy M, Roques M, Vidal H, Langin D. (2001) Triiodothyronine-mediated up-regulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes. FASEB J. 15:13-5. Barrientos A, Kenyon L, Moraes CT. (1998) Human xenomitochondrial cybrids. Cellular models of mitochondrial complex I deficiency. J Biol Chem. 273:14210-7. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444:337-42. Boelen A1, Wiersinga WM, Fliers E. (2008) Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid. 18:123-9. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H, Rieusset J. (2008) Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest. 118:789-800. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM. (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 481:463-8. Branvold DJ, Allred DR, Beckstead DJ, Kim HJ, Fillmore N, Condon BM, Brown JD, Sudweeks SN, Thomson DM, Winder WW. (2008) Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1alpha in rat muscle. J Appl Physiol (1985). 105:1218-27. Bugge A, Siersbaek M, Madsen MS, Gondor A, Rougier C, Mandrup S. (2010) A novel intronic peroxisome proliferator-activated receptor gamma enhancer in the uncoupling protein (UCP) 3 gene as a regulator of both UCP2 and -3 expression in adipocytes. J Biol Chem. 285:17310-7. Cannon B, Nedergaard J. (2004) Brown adipose tissue: function and physiological significance. Physiol. Rev. 84:277–359. Canto C, Auwerx J. (2010) AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci. 67:3407-23. Casas F, Pessemesse L, Grandemange S, Seyer P, Gueguen N, Baris O, Lepourry L, Cabello G, Wrutniak-Cabello C. (2008) Overexpression of the mitochondrial T3 receptor p43 induces a shift in skeletal muscle fiber types. PLoS One. 3:e2501. Chan DC. (2012) Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet. 46:265-87. Chan LL, Chen Q, Go AG, Lam EK, Li ET. (2005) Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression. J Nutr. 135:2517-23. Chaturvedi P, Akala H. (2003) Assessment of thyrogenic responses of M. charantia. J Appl Zool Res. 14:193–7. Chaturvedi P. (2012) Antidiabetic Potentials of Momordica charantia: Multiple Mechanisms Behind the Effects. J Med Food. 15:101–7. Chuang CY, Hsu C, Chao CY, Wein YS, Kuo YH, Huang CJ. (2006) Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). J Biomed Sci. 13:763-72. Cordeiro A, de Souza LL, Oliveira LS, Faustino LC, Santiago LA, Bloise FF, Ortiga-Carvalho TM, Almeida NA, Pazos-Moura CC. (2013) Thyroid hormone regulation of Sirtuin 1 expression and implications to integrated responses in fasted mice. J Endocrinol. 216:181-93. Croteau W, Davey JC, Galton VA, St Germain DL. (1996) Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest. 98:405-17. Day C, Cartwright T, Provost J, Bailey CJ. (1990) Hypoglycaemic effect of Momordica charantia extracts. Planta Med. 56:426–9. DeFronzo RA, Tobin JD, Andres R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-23. DeFronzo RA, Tripathy D. (2009) Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 32:S157-63. Egli RJ, Di Criscio A, Hempfing A, Schoeniger R, Ganz R, Hofstetter W, Leunig M. (2008) In vitro resistance of articular chondrocytes to 5-Aminolevulinic acid based photodynamic therapy. Lasers Surg Med. 40:282-90. Esteves TC, Brand MD. (2005) The reactions catalysed by the mitochondrial uncoupling proteins UCP2 and UCP3. Biochim Biophys Acta. 1709:35-44. Evans RM, Barish GD, Wang YX. (2004) PPARs and the complex journey to obesity. Nat Med. 10:355-61. Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, Reiner E. (2003) Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem. 312:224-7. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. (2005) Role of mitochondria in toxic oxidative stress. Mol Interv. 5:94-111. Fedorenko A, Lishko PV, Kirichok Y. (2012) Mechanism of Fatty-Acid-Dependent UCP1 Uncoupling in Brown Fat Mitochondria. Cell. 151:400-13. Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, Lambert PD, Mataki C, Elliott PJ, Auwerx J. (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 8:347-58. Freeman HC, Hugill A, Dear NT, Ashcroft FM. Cox RD. (2006) Deletion of nicotinamide nucleotide transhydrogenase; a new quantitative trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 55:2153-6. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. (2002) Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem. 277:48115-21. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 26:1913-23. Gnaiger E. (2009) Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol. 41:1837-45. Gong DW, He Y, Karas M, Reitman M. (1997) Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J Biol Chem. 272:24129-32. Gregory FO. (2010) Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann. N.Y. Acad. Sci. 1199:1–14. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48:1270-4. Guilherme A, Virbasius JV, Puri V, Czech MP. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 9:367-77. Gurd BJ, Yoshida Y, Lally J, Holloway GP, Bonen A. (2009) The deacetylase enzyme SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis. J Physiol. 587:1817-28. Harper JA, Stuart JA, Jekabsons MB, Roussel D, Brindle KM, Dickinson K, Jones RB, Brand MD. (2002) Artifactual uncoupling by uncoupling protein 3 in yeast mitochondria at the concentrations found in mouse and rat skeletal-muscle mitochondria. Biochem J. 361:49-56. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 460:392-5. Higashida K, Kim SH, Jung SR, Asaka M, Holloszy JO, Han DH. (2013) Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation. PLoS Biol. 11:e1001603. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. (2002) A central role for JNK in obesity and insulin resistance. Nature. 420:333-6. Holloszy JO. (2013) 'Deficiency' of mitochondria in muscle does not cause insulin resistance. Diabetes. 62:1036-40. Huang CJ, Wu MC. (2002) Differential effects of foods traditionally regarded as 'heating' and 'cooling' on prostaglandin E(2) production by a macrophage cell line. J Biomed Sci. 9:596-606. Huang TN, Lu KN, Pai YP, Chin Hsu, Huang CJ. (2013) Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter Gourd. Evid Based Complement Alternat Med. 2013:625892. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 61:1725-38. Irrcher I, Walkinsaw DR, Sheehan TE, Hood DA. (2008) Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo. J Appl Physiol. 104:178–85. Johannsen DL, Galgani JE, Johannsen NM, Zhang Z, Covington JD, Ravussin E. (2012) Effect of short-term thyroxine administration on energy metabolism and mitochondrial efficiency in humans. PLoS One. 7:e40837. Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, Milburn M. (2011) Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism. 60:404-13. Kelly DP, Scarpulla RC. (2004) Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18:357-68. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7:45-56. Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM. (2001) The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes. 109:S189-201. Kung J, Henry RR. (2012) Thiazolidinedione safety. Expert Opin. Drug Saf. 11:565–79. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127:1109-22. Liu D, Lin Y, Kang T, Huang B, Xu W, Garcia-Barrio M, Olatinwo M, Matthews R, Chen YE, Thompson WE. (2012) Mitochondrial dysfunction and adipogenic reduction by prohibitin silencing in 3T3-L1 cells. PLoS One. 7:e34315. Lopez LC, Akman HO, Garcia-Cazorla A, Dorado B, Marti R, Nishino I, Tadesse S, Pizzorno G, Shungu D, Bonilla E, Tanji K, Hirano M. (2009) Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet. 18:714-22. Lowell BB, Shulman GI. (2005) Mitochondrial Dysfunction and Type 2 Diabetes. Science 307:384-7. Lu KN, Hsu C, Chang ML, Huang CJ. (2013) Wild bitter gourd increased metabolic rate and up-regulated genes related to mitochondria biogenesis and UCP-1 in mice. J Func Foods. 5:668-78. Mangge H, Summers KL, Meinitzer A, Zelzer S, Almer G, Prassl R, Schnedl WJ, Reininghaus E, Paulmichl K, Weghuber D, Fuchs D. (2014) Obesity-related dysregulation of the tryptophan-kynurenine metabolism: Role of age and parameters of the metabolic syndrome. Obesity. 22:195-201. Martin WH 3rd, Murphree SS, Saffitz JE. (1989) Beta-adrenergic receptor distribution among muscle fiber types and resistance arterioles of white, red, and intermediate skeletal muscle. Circ Res. 64:1096-105. Masaki T, Yoshimatsu H, Kakuma T, Hidaka S, Kurokawa M, Sakata T. (1997) Enhanced expression of uncoupling protein 2 gene in rat white adipose tissue and skeletal muscle following chronic treatment with thyroid hormone. FEBS Lett. 418:323-6. McBride HM , Neuspiel M, Wasiak S. (2006) Mitochondria: more than just a powerhouse. Curr Biol. 16:R551-60. Monickaraj F, Aravind S, Gokulakrishnan K, Sathishkumar C, Prabu P, Prabu D, Mohan V, Balasubramanyam M. (2012) Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem. 365:343-50. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 34:267-73. Morino K, Petersen KF, Shulman GI. (2006) Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes. 55:S9-S15. Muoio DM, Newgard CB. (2006) Obesity-related derangements in metabolic regulation. Annu Rev Biochem. 75:367-401. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, Kang H, Shaw RJ, Evans RM. (2008) AMPK and PPARdelta agonists are exercise mimetics. Cell. 134:405-15. Nemoto S, Fergusson MM, Finkel T. (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem. 280:16456-60. Nerurkar PV, Lee YK, Motosue M, Adeli K, Nerurkar VR. (2008) Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phos- phoinositide-3 kinase interactions. Br J Nutr. 5:1–9. Ng M et al. (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. pii: S0140-6736(14)60460-8. Nicholson JK, Lindon JC, Holmes E. (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29:1181-9. Noguchi R, Yasui Y, Suzuki R, Hosokawa M, Fukunaga K, Miyashita K. (2001) Dietary effects of bitter gourd oil on blood and liver lipids of rats. Arch Biochem Biophys. 396:207-12. Nunnari J, Suomalainen A. (2012) Mitochondria: in sickness and in health. Cell. 148:1145-59. Oberkofler H, Klein K, Felder TK, Krempler F, Patsch W. (2006) Role of peroxisome proliferator-activated receptor-gamma coactivator-1alpha in the transcriptional regulation of the human uncoupling protein 2 gene in INS-1E cells. Endocrinology. 147:966-76. Oliver SG, Winson MK, Kell DB, Baganz F. (1998) Systematic functional analysis of the yeast genome. Trends Biotechnol. 16:373-8. O'Neill HM, Maarbjerg SJ, Crane JD, Jeppesen J, Jorgensen SB, Schertzer JD, Shyroka O, Kiens B, van Denderen BJ, Tarnopolsky MA, Kemp BE, Richter EA, Steinberg GR. (2011) AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A. 108:16092-7. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 100:8466-71. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350:664–671. Phielix E, Meex R, Moonen-Kornips E, Hesselink MK, Schrauwen P. (2010) Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia. 53:1714-21. Picard M, Juster RP, McEwen BS. (2014) Mitochondrial allostatic load puts the 'gluc' back in glucocorticoids. Nat Rev Endocrinol. 10:303-10. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, Cani PD, Ebersberger I, Nakashima T, Sarao R, Neely G, Esterbauer H, Kozlov A, Kahn CR, Kroemer G, Rustin P, Burcelin R, Penninger JM. (2007) Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell. 131:476-91. Reaven GM. (1988) Role of insulin resistance in human disease. Diabetes 37:1595-1607. Reeves PG, Nielsen FH, Fahey GC Jr. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 123:1939-51. Reilly JM, Thompson MP. (2000) Dietary fatty acids Up-regulate the expression of UCP2 in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 277:541–5. Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T. (2003) Mitochondrial threshold effects. Biochem J. 370:751-62. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 29:99-108. Sarkar S, Pranav M, Marita R. (1996) Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res. 33:1–4. Scarpulla RC. (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 88:611-38. Shier D, Butler JL, Lewis R. (2004) Hole's Human Anatomy and Physiology, 10th Edition. Silva JE. (1995) Thyroid hormone control of thermogenesis and energy balance. Thyroid. 5:481-92. Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ, Savoye M, Rothman DL, Shulman GI, Caprio S. (2002) Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes. 5:1022-7. Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D'Adamo P, Calvo S, Marsano RM, Donnini C, Weiher H, Strisciuglio P, Parini R, Sarzi E, Chan A, DiMauro S, Rotig A, Gasparini P, Ferrero I, Mootha VK, Tiranti V, Zeviani M. (2006) MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet. 38:570-5. Sudha BB, Kahn CR. (2006) From mice to men: insight tinto the insulin resistence syndromes. Annu. Rev. Physiol. 68:123-58. Suen DF, Norris KL, Youle RJ. (2008) Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577-90. Suhre K, Meisinger C, Doring A, Altmaier E, Belcredi P, Gieger C, Chang D, Milburn MV, Gall WE, Weinberger KM, Mewes HW, Hrabe de Angelis M, Wichmann HE, Kronenberg F, Adamski J, Illig T. (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One. 5:e13953. Tan MJ, Ye JM, Turner N, Honen-Behrens C, Ke CQ, Tang CP, Chen T, Weiss HC, Gesing ER, Rowland A, James DE, Ye Y. (2008) Antidiabetic activities of triterpenoids isolated from bitter melon associated with the activation of AMPK pathway. Chem Biol. 15:263–73. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J. (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A. 100:15924-9. Toda C, Diano S. (2014) Mitochondrial UCP2 in the central regulation of metabolism. Best Pract Res Cl En. Epub. http://dx.doi.org/10.1016/j.beem.2014.02.006 Tongia A, Tongia SK, Mangala D. (2004) Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus. Indian J Physiol Pharmacol. 48:241–4. Tsai CH, Chen EC, Tsay HS, Huang CJ. (2010) Bitter gourd (Momordica charantia): a review of its efficacy and safety for glucose homeostasis. Nutr Sci J. 35:115-26. Van der Bliek AM, Shen Q, Kawajiri S. (2013) Mechanisms of mitochondrial fission and fusion. Cold Spring Harb Perspect Biol. 5: a011072. Van Buul-Offers S, Hackeng WH, Schopman W. (1983) Thyroxine and triiodothyronine levels in Snell mice. Acta Endocrinol (Copenh). 102:396-409. Vernochet C, Mourier A, Bezy O, Macotela Y, Boucher J, Rardin MJ, An D, Lee KY, Ilkayeva OR, Zingaretti CM, Emanuelli B, Smyth G, Cinti S, Newgard CB, Gibson BW, Larsson NG, Kahn CR. (2012) Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab. 16:765-76. Viscomi C, Bottani E, Civiletto G, Cerutti R, Moggio M, Fagiolari G, Schon EA, Lamperti C, Zeviani M. (2011) In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis. Cell Metab. 14:80-90. Vozza A, Parisi G, De Leonardis F, Lasorsa FM, Castegna A, Amorese D, Marmo R, Calcagnile VM, Palmieri L, Ricquier D, Paradies E, Scarcia P, Palmieri F, Bouillaud F, Fiermonte G. (2014) UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci U S A. 111:960-5. Walrand S, Short KR, Heemstra LA, Novak CM, Levine JA, Coenen-Schimke JM, Nair KS. (2014) Altered regulation of energy homeostasis in older rats in response to thyroid hormone administration. FASEB J. 28:1499-510. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 439:484-9. Weber H. (1966) Rasche und einfache Ultramikromethode zur Bestim- mung der Serumcholinesterase. Dtsch. Med. WSchr. 91:1927–32. Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS. (1986) Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol. 17:277–82. Wolowczuk I, Hennart B, Leloire A, Bessede A, Soichot M, Taront S, Caiazzo R, Raverdy V, Pigeyre M; ABOS Consortium, Guillemin GJ, Allorge D, Pattou F, Froguel P, Poulain-Godefroy O. (2012) Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regul Integr Comp Physiol. 303:135-143. Wong CM, NGTB, Yeung HW. (1985) Screening of Trichosanthes kirilowi, Momordica charantia and Cucurbita maxima for compound with antilipolytic activity. J Ethnopharmacol. 13:312–32. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98:115-24. Yi L, He J, Liang Y, Yuan D, Gao H, Zhou H. (2007) Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients. Chem Phys Lipids. 150:204-16. Ylikallio E, Tyynismaa H, Tsutsui H, Ide T, Suomalainen A. (2010) High mitochondrial DNA copy number has detrimental effects in mice. Hum Mol Genet. 19:2695-705. Yoon YS, Yoon DS, Lim IK, Yoon SH, Chung HY, Rojo M, Malka F, Jou MJ, Martinou JC, Yoon G. (2006) Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J Cell Physiol. 209:468-80. Zechner C, Lai L, Zechner JF, Geng T, Yan Z, Rumsey JW, Collia D, Chen Z, Wozniak DF, Leone TC, Kelly DP. (2010) Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab. 12:633-42. 王麗卉 (2013) 共軛脂肪酸對C57BL/6J 雌鼠脂質代謝之影響國立臺灣大學生化科技學系碩士論文 行政院衛生福利部國民健康署 (2007) 修正我國代謝症候群之判定標準 行政院衛生福利部國民健康署 (2014) 民國102年死因統計結果分析 周怡君 (2010) 以脂肪與肌肉細胞模式評估山苦瓜水萃物暨其區分物對細胞汲取葡萄糖之影響與其機制探討 國立臺灣大學生化科技學系碩士論文 馮文嘉 (2012) 以FL83B肝臟細胞株汲取葡萄糖及HIT-T15胰臟細胞株胰島素分泌為平台研究山苦瓜之血糖調節活性萃物 國立臺灣大學生化科技學系碩士論文 蔡豐隆 (2012) 山苦瓜萃取物經納豆菌NTU-18去醣基化作用之效果探討 國立臺灣大學生化科技學系碩士論文 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56512 | - |
dc.description.abstract | 肥胖與代謝症候群是許多疾病的危險因子,包括第二型糖尿病、心血管疾病及癌症等,其全球盛行率逐年攀升,是近年來最重要的公衛議題之一。苦瓜(Momordica charantia L.)是熱帶地區常見的瓜類蔬菜,已有許多研究證實其能有效降低血糖及調節血脂異常。本實驗室先前曾發現添加5%山苦瓜全果凍乾粉(BGP)於高蔗糖飼料,可促進肌肉PGC-1α及TFAM基因表現量增加。此篇研究將更深入探討其是否促進骨骼肌粒線體增殖,藉以增加能量消耗與改善胰島素敏感性。第一部分實驗期為8週,採雙因子試驗設計,試驗因子為BGP及飼料脂質含量。發現BGP均改善低脂高蔗糖或高脂飲食誘導肥胖,降低血糖、脂質堆積及體重增加,提昇血清中三碘甲狀腺素(T3),且二因子間無交互作用。但對肌肉粒線體相關基因表現量及粒線體含量未造成影響。另外進行代謝體學研究則觀察到苦瓜三萜類化合物出現於肝臟之證據,且膽酸代謝、前列腺素代謝及色胺酸代謝路徑可能受到苦瓜攝取之影響。第二部分以注射T3之動物模式,建立分析粒線體增殖方法並確認其可信度,並依肌纖維組成分別取紅肌及白肌進行分析。T3處理5週後顯著增加小鼠氧氣消耗及二氧化碳排出,且T3主要作用於紅肌,刺激TFAM、COX7a1及UCP2基因mRNA 表現量增加,粒線體含量指標mtDNA copy number與檸檬酸合成酶(CS)活性卻未受影響。第三部分將實驗飼料餵食週數延長至25 週,在高蔗糖飼料中添加5% BGP,同樣顯著降低血中三酸甘油酯、脂質堆積及體重增加量,提高基礎代謝率與胰島素敏感性,且血糖低於餵食chow diet的正常飲食組。儘管血中T3濃度沒有差異,BGP提高肌肉中DIO2基因表現。高糖飲食造成白肌中粒線體相關基因表現下降,BGP則恢復其表現,並在紅肌中相較其他兩組有更高表現。而注射T3 與長期餵食BGP的小鼠皆觀察到紅肌中UCP2基因表現增加。然而在PGC-1α、NRF1及TFAM基因皆提昇的情況下,mtDNA copy number及CS活性未顯著提昇,組織氧氣消耗速率及胞外酸化速率亦未受影響,但紅肌中OCR/ECAR比值顯著較C組高。綜之,BGP確實可降低血糖及三酸甘油酯,改善胰島素敏感性,可能透過促進血中或肌肉組織之T3作用,提高基礎代謝率,以及肌肉中粒線體相關基因表現增加以避免飲食誘導肥胖。 | zh_TW |
dc.description.abstract | Obesity is a risk factor for various chronic diseases, and it has become a worldwide health issue due to the increasing global prevalence. Bitter gourd (Momordica charantia L.) is a common tropical vegetable, which has been shown to prevent metabolic disorder and obesity. Previous studies in our laboratory demonstrated that supplementation of 5% lyophilized wild bitter gourd powder (BGP) to a high sucrose diet up-regulated PGC-1α and TFAM mRNA expression in the muscle. This study thus tested the hypothesis that BGP might increase mitochondrial biogenesis in skeletal muscle, increase energy expenditure and ameliorate insulin resistance.
In the first experiment, 4 groups of C57BL/6J male mice were respectively fed high sucrose (HS) or high fat diets supplemented without or with 5% BGP based on a 2X2 factorial design. After 8 weeks of feeding, BGP significantly reduced serum glucose and triglyceride level, adipose mass, and body weight change and increased serum triiodothyronine (T3). But BGP did not affect mitochondria-related gene expression or mitochondria content in skeletal muscle. Through the metabolomic studies, we found supporting evidence that triterpenoid compounds of bitter gourd accumulated in liver of mice fed BGP. In addition, bile acid metabolism, prostaglandin metabolism and tryptophan metabolism might be affected by BGP. In the second experiment, mice were daily injected with triiodothyronin (T3) (50 μg/kg/day) for 5 weeks to establish and validate the methods for evaluate mitochondria biogenesis in skeletal muscle. T3 significantly increased O2 consumption and CO2 production of animals, and stimulated TFAM, COX7a1 and UCP2 gene expression mainly in slow-twitch oxidative skeletal muscle. However, PGC-1α level, mitochondrial DNA (mtDNA) copy number and citrate synthase (CS) activity were not altered. In the third experiment, 3 groups of mice were respectively fed the HS, HS+5% BGP or chow diets for 25 weeks. Similar to results in the first experiment, BGP inhibited diet-induced obesity and reduced serum glucose to a level that was even lower than that of the chow diet-fed mice. In spite of unchanged serum T3 level, BGP up-regulated DIO2 gene expression in both glycolytic and oxidative muscle and UCP2 level in oxidative muscle. High sucrose diet down-regulated mitochondria- related gene expression in glycolytic muscle, but BGP restored it to the normal level. The expression levels of these genes in the oxidative muscle of the BG group were higher than those of the other 2 groups. BG did not significantly change mtDNA copy number, CS activity, tissue oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), but increase the OCR/ECAR ratio. In summary, BGP reduced serum glucose and triglyceride level, improved insulin sensitivity, increase metabolic rate, up-regulated mRNA expressions of DIO2, UCP2 and mitochondria-related gene expression in glycolytic and oxidative muscle. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T05:32:19Z (GMT). No. of bitstreams: 1 ntu-103-R01b22005-1.pdf: 8292878 bytes, checksum: e1906c29e8842323b30414ba99bd42a0 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 中文摘要................................................... i
英文摘要................................................. iii 縮寫對照表................................................. v 總目錄.................................................... ix 圖目錄................................................... xiv 表目錄.................................................. xvii 第一章、緒論................................................ 1 1.1 前言.................................................. 1 1.2 文獻回顧............................................... 1 1.2.1 肥胖與代謝性疾病....................................... 1 1.2.2 代謝性壓力對肌肉及粒線體之影響........................... 4 1.2.3 代謝體學............................................ 13 1.2.4 苦瓜............................................... 15 1.3 實驗假說與架構......................................... 18 第二章、初探小鼠攝入8週山苦瓜對肌肉粒線體含量與相關基因之影響暨代謝體學研究....................................................... 20 2.1 前言................................................. 20 2.2 材料與方法............................................ 21 2.2.1 試驗大綱............................................ 21 2.2.2 動物飼養............................................ 22 2.2.3 飼料配製............................................ 22 2.2.4 氧消耗量、二氧化碳排出量與呼吸商測定..................... 23 2.2.5 代謝物收集.......................................... 24 2.2.6 口服葡萄糖耐受性測試.................................. 24 2.2.7 動物犧牲............................................ 24 2.2.8 血液生化分析......................................... 24 2.2.8.1 血清葡萄糖........................................ 24 2.2.8.2 血清三酸甘油酯..................................... 25 2.2.8.3 血清膽固醇........................................ 26 2.2.8.4 血清胰島素........................................ 26 2.2.8.5 血清四碘甲狀腺素................................... 26 2.2.8.6 血清三碘甲狀腺素................................... 27 2.2.9 代謝體學............................................ 27 2.2.9.1 樣品製備.......................................... 27 2.2.9.2 液相層析質譜分析.................................... 28 2.2.9.3 分析結果資料擷取.................................... 30 2.2.10 Real-time PCR法分析基因表現與粒線體DNA複本數........... 31 2.2.11 統計分析........................................... 33 2.3 結果................................................. 33 2.3.1 體重變化、攝食量、飼料與能量利用率....................... 33 2.3.2 組織絕對與相對重量.................................... 34 2.3.3 氧消耗量、二氧化碳排出量及呼吸商......................... 34 2.3.4 餵食5週、8週之血液生化分析............................. 34 2.3.5口服葡萄糖耐受性測試................................... 34 2.3.6 肌肉粒線體含量與相關基因表現量.......................... 35 2.3.7 代謝體學............................................ 35 2.4 討論................................................. 58 2.5 結論................................................. 61 第三章、骨骼肌粒線體增生之動物模式建........................... 62 3.1 前言................................................. 62 3.2 材料與方法............................................ 64 3.2.1 試驗大綱............................................ 64 3.2.2 動物飼養............................................ 64 3.2.3 氧消耗量、二氧化碳排出量與呼吸商測定..................... 65 3.2.4 動物犧牲............................................ 65 3.2.5 粒線體分離與檸檬酸合成酶之酵素活性測定.................... 66 3.2.6 血液生化分析......................................... 67 3.2.7 Real-time PCR法分析基因表現與粒線體DNA複本數............ 67 3.2.8 穿透式電子顯微鏡切片分析............................... 70 3.2.9 統計分析............................................ 71 3.3 結果................................................. 71 3.3.1 體重變化、飼料及能量攝取與利用情形....................... 71 3.3.2 絕對與相對組織重量.................................... 71 3.3.3 氧氣消耗、二氧化碳排出及呼吸商.......................... 71 3.3.4 血液分析............................................ 72 3.3.5粒線體相關基因表現、mtDNA複本數與CS活性分析............... 72 3.3.6 穿透式電子顯微鏡組織切片分析............................ 72 3.4 討論................................................. 86 3.5 結論................................................. 89 第四章、探討小鼠飼以添加山苦瓜之高蔗糖飼料25週對肌肉粒線體增殖之影響. 90 4.1 前言................................................. 90 4.2 材料與方法............................................ 91 4.2.1 試驗大綱............................................ 91 4.2.2 動物飼養............................................ 92 4.2.3 飼料配製............................................ 92 4.2.4氧消耗量、二氧化碳排出量與呼吸商測定...................... 93 4.2.5 動物犧牲............................................ 94 4.2.6 組織氧氣消耗速率與胞外酸化速率分析....................... 94 4.2.7 粒線體分離與檸檬酸合成酶之酵素活性測定.................... 95 4.2.8 血液分析............................................ 95 4.2.9 Real-time PCR法分析基因表現與粒線體DNA複本數............ 95 4.2.10 穿透式電子顯微鏡切片分析.............................. 96 4.2.11統計分析............................................ 96 4.3 結果................................................. 96 4.3.1 體重變化、攝食量、飼料與能量利用率....................... 96 4.3.2 組織絕對與相對重量.................................... 97 4.3.3 氧消耗量、二氧化碳排出量及呼吸商......................... 97 4.3.4 血液生化分析......................................... 97 4.3.5 粒線體相關基因表現、mtDNA複本數與CS活性分析.............. 98 4.3.6 肌肉組織氧氣消耗速率與胞外酸化速率分析................... 98 4.4 討論................................................ 112 4.5 結論................................................ 116 第五章、綜合討論與結論...................................... 117 5.1 綜合討論............................................. 117 5.2 總結論............................................... 122 第六章、參考文獻........................................... 123 附錄一、預測代謝物與標準品資料庫之M/z at RT比較................ 140 附錄二、Chow diet (LabDiet) 飼料成分表..................... 142 附錄三、不同品系山苦瓜乙酸乙酯萃物對PPARδ之轉染活性............. 143 | |
dc.language.iso | zh-TW | |
dc.title | 探討山苦瓜對飲食誘導肥胖模式小鼠骨骼肌粒線體增殖之影響 | zh_TW |
dc.title | The Effects of Wild Bitter Gourd on Mitochondrial Biogenesis in Skeletal Muscle of Diet-induced Obese Mice | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 趙蓓敏(Pei-Min Chao),林甫容(Fu-Jung Lin),蕭明熙(Ming-Shi Shiao),龔秀妮(Hsiu-Ni Kung) | |
dc.subject.keyword | 苦瓜,骨骼肌,粒線體,甲狀腺素, | zh_TW |
dc.subject.keyword | bitter gourd,skeletal muscle,mitochondria,thyroid hormone, | en |
dc.relation.page | 143 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-08-13 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科技學系 | zh_TW |
顯示於系所單位: | 生化科技學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 8.1 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。